Nasal spray gene therapy offers hope for brain repair in cerebral palsy patients

This international registry follows people who have already received an experimental nasal spray gene therapy for brain damage caused by oxygen deprivation, which often leads to cerebral palsy. The therapy delivers 15 genes designed to help repair brain tissue, reduce inflammation, and improve nerve function. Researchers are collecting data from 25 participants across multiple countries to see if this treatment improves movement, thinking skills, and quality of life over two years.